Literature DB >> 4338448

Multiple sclerosis associated with defects in neuromuscular transmission.

B M Patten, A Hart, R Lovelace.   

Abstract

Three patients with multiple sclerosis characterized by exacerbations and remissions of nervous system signs and symptoms disseminated in time and space also had the kind of easy fatiguability seen in myasthenia gravis. In each case abnormal decrements to repetitive stimulation were electromyographically demonstrated and treatment with ephedrine or anticholinesterase drugs increased the patient's functional capacity while improving the electromyographic abnormality. The suggestion is that these patients represent an overlap syndrome, analogous to the overlap syndrome existing between systemic lupus erythematosus and rheumatoid arthritis where clinical and laboratory features of two diseases coexist in the same patient at the same time. Presumably some patients with multiple sclerosis have deficient production of acetylcholine, just like patients with myasthenia, and treatment with agents useful in myasthenia is able partially to correct the symptoms caused by the deficiency. The cases illustrate how in neurology greater attention to the more immediate cause of clinical symptoms, in the absence of a known aetiology, may result in benefit to the patients.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4338448      PMCID: PMC494081          DOI: 10.1136/jnnp.35.3.385

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  29 in total

1.  Applied electrophysiology in nerve and muscle disease. Disorders of neuromuscular transmission.

Authors:  J A Simpson
Journal:  Proc R Soc Med       Date:  1966-10

2.  Corticotropin in generalized myasthenia gravis. Effect of short, intensive courses.

Authors:  D Grob; T Namba
Journal:  JAMA       Date:  1966-11-14       Impact factor: 56.272

3.  Association of trimethadione therapy and myasthenia gravis.

Authors:  H Peterson
Journal:  N Engl J Med       Date:  1966-03-03       Impact factor: 91.245

Review 4.  Myasthenia gravis as an autoimmune disease: clinical aspects.

Authors:  J A Simpson
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

5.  Presynaptic mechanisms in myasthenia gravis.

Authors:  J E Desmedt
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

6.  Defects of neuromuscular transmission in syndromes other than myasthenia gravis.

Authors:  E H Lambert
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

7.  Muscle lesions in myasthenia gravis. Discussion.

Authors:  W K Engel; D E McFarlin
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

8.  Autoimmune hemolytic anemia and myasthenia gravis associated with thymoma.

Authors:  I C Halperin; W F Minogue; Z D Komninos
Journal:  N Engl J Med       Date:  1966-09-22       Impact factor: 91.245

9.  Familial multiple sclerosis associated with narcolepsy.

Authors:  K Ekbom
Journal:  Arch Neurol       Date:  1966-10

10.  Neuromuscular transmission in thyroid disease.

Authors:  F H Norris
Journal:  Ann Intern Med       Date:  1966-01       Impact factor: 25.391

View more
  7 in total

1.  Multiple sclerosis, euthyroid restrictive Grave's ophthalmopathy, and myasthenia gravis. A case report.

Authors:  W W Bixenman; H W Buchsbaum
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

2.  A case of myasthenia gravis associated with optic neuritis.

Authors:  A Ghezzi; M Zaffaroni; D Caputo; A Zibetti; G Mariani
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

3.  Multiple sclerosis associated with defective neuromuscular transmission.

Authors:  W Cendrowski
Journal:  J Neurol       Date:  1975-08-01       Impact factor: 4.849

Review 4.  Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes.

Authors:  Charlotte Vrinten; Angeli M van der Zwaag; Stephanie S Weinreich; Rob J P M Scholten; Jan J G M Verschuuren
Journal:  Cochrane Database Syst Rev       Date:  2014-12-17

5.  Single fibre electromyographic jitter in multiple sclerosis.

Authors:  A Weir; S Hansen; J P Ballantyne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-12       Impact factor: 10.154

6.  Circulating thyroid and gastric parietal cell autoantibodies in patients with multiple sclerosis.

Authors:  C Ioppoli; G Meucci; S Mariotti; E Martino; A Lippi; L Gironelli; A Pinchera; A Muratorio
Journal:  Ital J Neurol Sci       Date:  1990-02

7.  Multiple sclerosis and Hashimoto's thyroiditis.

Authors:  J Roquer; D Escudero; J Herraiz; E Masó; F Cano
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.